$9.10
-0.04-0.44%
Last update: Oct 30, 4:00 PM
Sutro Biopharma Inc (STRO) Stock Price, Quote, News & History
STRONASDAQ
Sutro Biopharma stock falls after its STRO-004 Phase 1 update, with DLTs reported at the highest dose and the next update planned for 2027.
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Other companies in Sutro Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Sutro Biopharma has a consensus price target of $52.95.
The stock price for Sutro Biopharma (NASDAQ: STRO) is $9.1 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Sutro Biopharma.
Sutro Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Sutro Biopharma.
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein...
